Page last updated: 2024-10-23

bis(5-amidino-2-benzimidazolyl)methane and Granulomatous Disease, Chronic

bis(5-amidino-2-benzimidazolyl)methane has been researched along with Granulomatous Disease, Chronic in 2 studies

bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geratz, JD2
Tidwell, RR2
Lombardy, RJ1
Schwab, JH2
Anderle, SK2
Pryzwansky, KB2

Other Studies

2 other studies available for bis(5-amidino-2-benzimidazolyl)methane and Granulomatous Disease, Chronic

ArticleYear
Streptococcal cell wall-induced systemic disease. Beneficial effects of trans-bis(5-amidino-2-benzimidazolyl)ethene, a novel, macrophage-directed anti-inflammatory agent.
    The American journal of pathology, 1991, Volume: 139, Issue:4

    Topics: Animals; Benzimidazoles; Cell Membrane; Female; Granulomatous Disease, Chronic; Inflammation; Liver;

1991
Suppression of streptococcal cell wall-induced arthritis by a potent protease inhibitor, bis(5-amidino-2-benzimidazolyl)methane.
    Arthritis and rheumatism, 1988, Volume: 31, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Benzimidazoles; Cell Wall; Ch

1988